A prognostic model for breast cancer was built based on the signature of these hub genes predicted as above, which was constructed by a linear combination of the Cox regression coefficients (β) multiplied with its mRNA expression pattern. In brief, the risk score of each patient was calculated by the formula that risk score = (βGene1 × expressionGene1) + (βGene2 × expressionGene2) +…+(βGeneN × expressionGeneN). Patients were grouped into high- or low-risk set according to the Youden index of their risk score, and the survival difference between these two sets was analyzed by the Kaplan–Meier estimation combined with a log-rank test in the testing datasets (TCGA-BRCA and METABRIC). Moreover, the predictive value of this model was further applied and validated into other datasets, such as the public GSE20685 cohort, GSE4922 cohort and our local FUSCC-TNBC dataset (GSE118527).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.